These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Structural basis for renal cancer by the dynamics of pVHL-dependent JADE1 stabilization and β-catenin regulation. Shafique S; Rashid S Prog Biophys Mol Biol; 2019 Aug; 145():65-77. PubMed ID: 30528740 [TBL] [Abstract][Full Text] [Related]
4. Tumor suppressor von Hippel-Lindau (VHL) stabilization of Jade-1 protein occurs through plant homeodomains and is VHL mutation dependent. Zhou MI; Wang H; Foy RL; Ross JJ; Cohen HT Cancer Res; 2004 Feb; 64(4):1278-86. PubMed ID: 14973063 [TBL] [Abstract][Full Text] [Related]
5. Candidate tumor suppressor and pVHL partner Jade-1 binds and inhibits AKT in renal cell carcinoma. Zeng L; Bai M; Mittal AK; El-Jouni W; Zhou J; Cohen DM; Zhou MI; Cohen HT Cancer Res; 2013 Sep; 73(17):5371-80. PubMed ID: 23824745 [TBL] [Abstract][Full Text] [Related]
6. Molecular cloning and characterization of the von Hippel-Lindau-like protein. Qi H; Gervais ML; Li W; DeCaprio JA; Challis JR; Ohh M Mol Cancer Res; 2004 Jan; 2(1):43-52. PubMed ID: 14757845 [TBL] [Abstract][Full Text] [Related]
7. Polycystin-1 C-terminal tail associates with beta-catenin and inhibits canonical Wnt signaling. Lal M; Song X; Pluznick JL; Di Giovanni V; Merrick DM; Rosenblum ND; Chauvet V; Gottardi CJ; Pei Y; Caplan MJ Hum Mol Genet; 2008 Oct; 17(20):3105-17. PubMed ID: 18632682 [TBL] [Abstract][Full Text] [Related]
8. Regulation of STRA13 by the von Hippel-Lindau tumor suppressor protein, hypoxia, and the UBC9/ubiquitin proteasome degradation pathway. Ivanova AV; Ivanov SV; Danilkovitch-Miagkova A; Lerman MI J Biol Chem; 2001 May; 276(18):15306-15. PubMed ID: 11278694 [TBL] [Abstract][Full Text] [Related]
9. The ciliary protein nephrocystin-4 translocates the canonical Wnt regulator Jade-1 to the nucleus to negatively regulate β-catenin signaling. Borgal L; Habbig S; Hatzold J; Liebau MC; Dafinger C; Sacarea I; Hammerschmidt M; Benzing T; Schermer B J Biol Chem; 2012 Jul; 287(30):25370-80. PubMed ID: 22654112 [TBL] [Abstract][Full Text] [Related]
10. von Hippel-Lindau partner Jade-1 is a transcriptional co-activator associated with histone acetyltransferase activity. Panchenko MV; Zhou MI; Cohen HT J Biol Chem; 2004 Dec; 279(53):56032-41. PubMed ID: 15502158 [TBL] [Abstract][Full Text] [Related]
11. Jade-1: its structure, regulation and functions in the renal cancer. Zhang YC; Du WQ; Zhang RY; Zheng JN; Pei DS Curr Mol Med; 2016; 16(1):63-9. PubMed ID: 26695694 [TBL] [Abstract][Full Text] [Related]
12. pVHL mediates K63-linked ubiquitination of nCLU. Xue J; Lv DD; Jiao S; Zhao W; Li X; Sun H; Yan B; Fan L; Hu RG; Fang J PLoS One; 2012; 7(4):e35848. PubMed ID: 22532874 [TBL] [Abstract][Full Text] [Related]
13. USP9X destabilizes pVHL and promotes cell proliferation. Zhang C; Peng Z; Zhu M; Wang P; Du X; Li X; Liu Y; Jin Y; McNutt MA; Yin Y Oncotarget; 2016 Sep; 7(37):60519-60534. PubMed ID: 27517496 [TBL] [Abstract][Full Text] [Related]
14. Jade-1, a candidate renal tumor suppressor that promotes apoptosis. Zhou MI; Foy RL; Chitalia VC; Zhao J; Panchenko MV; Wang H; Cohen HT Proc Natl Acad Sci U S A; 2005 Aug; 102(31):11035-40. PubMed ID: 16046545 [TBL] [Abstract][Full Text] [Related]
15. Role of the C-terminal alpha-helical domain of the von Hippel-Lindau protein in its E3 ubiquitin ligase activity. Lewis MD; Roberts BJ Oncogene; 2004 Mar; 23(13):2315-23. PubMed ID: 14691445 [TBL] [Abstract][Full Text] [Related]
16. The C-terminal tail of polycystin-1 regulates complement factor B expression by signal transducer and activator of transcription 1. Wu M; Chen M; Jing Y; Gu J; Mei S; Yao Q; Zhou J; Yang M; Sun L; Wang W; Hu H; Wüthrich RP; Mei C Am J Physiol Renal Physiol; 2016 Jun; 310(11):F1284-94. PubMed ID: 26984954 [TBL] [Abstract][Full Text] [Related]
17. Polycystin-1 regulates STAT activity by a dual mechanism. Talbot JJ; Shillingford JM; Vasanth S; Doerr N; Mukherjee S; Kinter MT; Watnick T; Weimbs T Proc Natl Acad Sci U S A; 2011 May; 108(19):7985-90. PubMed ID: 21518865 [TBL] [Abstract][Full Text] [Related]
18. Molecular targets from VHL studies into the oxygen-sensing pathway. Maynard MA; Ohh M Curr Cancer Drug Targets; 2005 Aug; 5(5):345-56. PubMed ID: 16101382 [TBL] [Abstract][Full Text] [Related]
19. Identification of cyclin D1 and other novel targets for the von Hippel-Lindau tumor suppressor gene by expression array analysis and investigation of cyclin D1 genotype as a modifier in von Hippel-Lindau disease. Zatyka M; da Silva NF; Clifford SC; Morris MR; Wiesener MS; Eckardt KU; Houlston RS; Richards FM; Latif F; Maher ER Cancer Res; 2002 Jul; 62(13):3803-11. PubMed ID: 12097293 [TBL] [Abstract][Full Text] [Related]
20. Human ADPKD primary cyst epithelial cells with a novel, single codon deletion in the PKD1 gene exhibit defective ciliary polycystin localization and loss of flow-induced Ca2+ signaling. Xu C; Rossetti S; Jiang L; Harris PC; Brown-Glaberman U; Wandinger-Ness A; Bacallao R; Alper SL Am J Physiol Renal Physiol; 2007 Mar; 292(3):F930-45. PubMed ID: 17090781 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]